Pharma major Wockhardt Friday said it is hopeful of early resolution of the issues with the US Food and Drug Administration (FDA), which has hit... ...http://echoofindia.com/mumbai-wockhardt-hopes-usfda-row-will-be-resolved-early-86200
Posted by Equitymaster Indian equity markets traded firm in today's session despite negative global cues. The Indian indices began the day's... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/LtQ-tNTwkJs/tm.asp
eneric drug-maker Wockhardt Ltd’s inability to sell most of its products in the US because of restrictions on their imports from India... ...http://forbesindia.com/article/special/wockhardts-net-profit-in-q4-falls-to-rs-34-cr/40375/1
New Delhi, May 29 (PTI) Glenmark Pharmaceuticals today said it has received the final approval from US health regulator for its generic version of... ...http://www.ptinews.com/news/6084810_Glenmark-gets-USFDA-nod-for-generic-diabetes-drug-.html
The Indian equity market closed with marginal losses on Thursday amid a volatile F&O expiry session led by losses in the Banking, Healthcare and... ...http://www.indiainfoline.com/article/news-top-story/f-o-expiry-sensex-nifty-see-marginal-losses-115052800801_1.html
SORBEAD INDIA is offering a wide...
Miocon is pleased to introduce...